# Doxazosin for Psychostimulant Dependence

> **NCT01371851** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Arkansas** · enrollment: 22 (actual)

## Conditions studied

- Methamphetamine or Cocaine Dependence

## Interventions

- **DRUG:** Doxazosin extended release

## Key facts

- **NCT ID:** NCT01371851
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2015-07-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01371851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01371851, "Doxazosin for Psychostimulant Dependence". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01371851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*